European Innovation Council

Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.

Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.

Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Abzu is a scientific artificial intelligence company founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain. The company develops the QLattice, an innovative AI platform that aims to challenge conventional black box AI by providing transparent and explainable models. Abzu's technology is designed to assist pharmaceutical and biotech companies in accelerating drug development processes. By unlocking new disease mechanisms, discovering novel biomarkers, and validating multiple targets simultaneously, Abzu enables these companies to reduce research and development costs and enhance their discovery capabilities. Through its pioneering approach, Abzu inspires data scientists to adopt a more scientific methodology in their work.

Kaffe Bueno ApS is a Danish company established in 2016 that specializes in upcycling coffee waste to create ingredients for cosmetics, functional foods, and nutraceuticals. Utilizing proprietary biotechnology and green chemistry, Kaffe Bueno transforms spent coffee grounds into valuable products such as coffee oils, coffee flour, and coffee beans. The company's mission is to maximize the usability of coffee by-products while minimizing harmful emissions, thereby redefining the perception of coffee from merely a beverage to a potent source of health benefits. Kaffe Bueno caters to a diverse range of clients, including industrial coffee producers, cafes, hotels, and offices, enabling them to contribute to sustainable practices through the upcycling of coffee waste.

Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.

MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.

NIL Technology ApS specializes in the optical design, prototyping, mastering, and mass production of optical components. The company provides nanostructured masters for various replication technologies, including nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product offerings support a wide range of applications, such as diffractive optics, microlens arrays, metalenses, optical diffusers, beam splitters, waveguides for augmented and mixed reality, wire grid polarizers, structured light systems, and anti-reflection coatings. NIL Technology also develops tailored solutions for industries including biotechnology, space, consumer product packaging, and renewable energy. Established in 2006, the company is headquartered in Kongens Lyngby, Denmark, with an additional branch located in Gothenburg, Sweden.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

MedTrace Pharma A/S, founded in 2015 and headquartered in Kongens Lyngby, Denmark, specializes in medical technology focused on improving positron emission tomography (PET) imaging. The company has developed an automated system, known as MT-100, which facilitates the bedside production and infusion of radioactive water, specifically 15O-water, into patients during PET scans. This innovative approach enhances the sensitivity of imaging results and significantly increases patient throughput. Complementing the MT-100 system is aQuant, an analytical software platform designed to interpret the PET scan data generated from the use of 15O-water. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace Pharma aims to advance clinical practices in diagnostic imaging through its cutting-edge technology.

NIL Technology ApS specializes in the optical design, prototyping, mastering, and mass production of optical components. The company provides nanostructured masters for various replication technologies, including nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product offerings support a wide range of applications, such as diffractive optics, microlens arrays, metalenses, optical diffusers, beam splitters, waveguides for augmented and mixed reality, wire grid polarizers, structured light systems, and anti-reflection coatings. NIL Technology also develops tailored solutions for industries including biotechnology, space, consumer product packaging, and renewable energy. Established in 2006, the company is headquartered in Kongens Lyngby, Denmark, with an additional branch located in Gothenburg, Sweden.

NIL Technology ApS specializes in the optical design, prototyping, mastering, and mass production of optical components. The company provides nanostructured masters for various replication technologies, including nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product offerings support a wide range of applications, such as diffractive optics, microlens arrays, metalenses, optical diffusers, beam splitters, waveguides for augmented and mixed reality, wire grid polarizers, structured light systems, and anti-reflection coatings. NIL Technology also develops tailored solutions for industries including biotechnology, space, consumer product packaging, and renewable energy. Established in 2006, the company is headquartered in Kongens Lyngby, Denmark, with an additional branch located in Gothenburg, Sweden.